UPEXI, INC. Files Definitive Proxy Statement
Ticker: UPXI · Form: DEF 14A · Filed: May 12, 2025 · CIK: 1775194
| Field | Detail |
|---|---|
| Company | Upexi, Inc. (UPXI) |
| Form Type | DEF 14A |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, sec-filing
TL;DR
UPEXI filed its proxy statement, shareholders vote soon.
AI Summary
UPEXI, INC. filed its definitive proxy statement (DEF 14A) on May 12, 2025, for the fiscal year ending June 30, 2025. The company, formerly known as GROVE, INC. until April 29, 2019, is based in Tampa, Florida, and operates in the medicinal chemicals & botanical products sector. The filing details information related to the upcoming shareholder meeting and voting matters.
Why It Matters
This filing provides shareholders with crucial information regarding voting rights and company governance, enabling them to make informed decisions at the upcoming shareholder meeting.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently indicate new risks.
Key Numbers
- 001-40535 — SEC File Number (Identifies the company's filings with the SEC.)
- 0001775194 — Central Index Key (Unique identifier for the company in the SEC's EDGAR system.)
Key Players & Entities
- UPEXI, INC. (company) — Registrant
- GROVE, INC. (company) — Former company name
- May 12, 2025 (date) — Filing date
- 20250428 (date) — Report period
- 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 (address) — Company business address
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important matters such as the election of directors, executive compensation, and other corporate actions.
When was UPEXI, INC. formerly known as GROVE, INC.?
UPEXI, INC. was formerly known as GROVE, INC. until April 29, 2019.
What is UPEXI, INC.'s fiscal year end?
UPEXI, INC.'s fiscal year ends on June 30.
What industry does UPEXI, INC. operate in?
UPEXI, INC. operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, with SIC code 2833.
Where is UPEXI, INC. headquartered?
UPEXI, INC. is headquartered in Tampa, Florida, with its business address at 3030 Rocky Point Drive, Suite 420, Tampa, FL 33607.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 12, 2025 regarding UPEXI, INC. (UPXI).